China Medical System says Dermavon gets NMPA approval for Lumirix NDA
China Medical System Holdings Limited says Dermavon received NMPA approval for its Lumirix NDA for atopic dermatitis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.